Reading the Evidence
Heard FDA “approved” BPC-157? It didn’t. A panel voted in July to let pharmacies compound six peptides, and nothing has legally changed yet. The three lanes a peptide can sit in, and where BPC-157 and TB-500 stand as …
Reading the Evidence
The badge says “99% pure.” That’s one number from one test. What else is in a synthetic peptide, why regulators flag it, and what a complete certificate of analysis should list.
Reading the Evidence
Seen BPC-157 pitched for tendon pain that won’t quit? More than two decades of rat studies, a 2026 head-to-head with TB-500 and a 2025 review of 36 studies: what was measured, what was found and where the evidence stops.
Reading the Evidence
BPC-157, TB-500, GHK-Cu, collagen: the group chat is sure. Here’s what’s actually been studied in people, what hasn’t, and what to ask at your next post-op visit.
Reading the Evidence
Three suppliers, three “99% purity” badges, three very different levels of proof. How to read a certificate of analysis line by line, and the six checks that matter.
Reading the Evidence
Your crew lead swears by “the combo.” But BPC-157 and TB-500 are different molecules with very different evidence. What each one is, what’s been studied in people, and what the FDA said in 2026.
Reading the Evidence
Green score, sore shoulder? A recovery score reads your whole system, not one injured joint. What it can and can’t tell you, and which signal wins when they disagree.
Reading the Evidence
A good day feels like a cure. A bad day feels like failure. Neither is true. How to track pain, function, activity and confidence separately, and see the trend that matters.
Reading the Evidence
Garage full of recovery gear, and the knee still hurts? “Accelerates recovery” is a slogan. A one-page test to run before the next gadget, supplement or service goes in your cart.
Reading the Evidence
Your buddy swears it fixed his shoulder, and he isn’t lying. The question is what it proves. Six questions to ask before a recovery story turns into a purchase or a treatment decision.
Reading the Evidence
Forums say it cuts recovery in half. Here’s every rung of the evidence, what the FDA and its July 2026 advisory vote actually mean, and the questions to bring your surgeon.